ICRM
IBB icon

Insight Capital Research & Management’s iShares Biotechnology ETF IBB Stock Holding History

Insight Capital Research & Management’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-3,045
Closed -$269K – 94
2016
Q4 		$269K Hold
3,045
– – 0.14% 104
2016
Q3 		$294K Hold
3,045
– – 0.13% 93
2016
Q2 		$261K Hold
3,045
– – 0.09% 96
2016
Q1 		$265K Sell
3,045
-1,245
-29% -$111K 0.08% 91
2015
Q4 		$484K Buy
4,290
+360
+9% +$39.1K 0.14% 90
2015
Q3 		$397K Hold
3,930
– – 0.12% 84
2015
Q2 		$483K Hold
3,930
– – 0.13% 93
2015
Q1 		$450K Hold
3,930
– – 0.11% 108
2014
Q4 		$397K Hold
3,930
– – 0.1% 119
2014
Q3 		$358K Buy
+3,930
New +$345K 0.09% 109

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return